香港股市 已收市

巨子生物 (2367.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
48.050+0.350 (+0.73%)
收市:04:08PM HKT

巨子生物

No. 1855, Shanglin Yuan
7th Road Chang’an District
Xi’an
China
86 29 8115 6502
https://www.xajuzi.com

版塊Consumer Defensive
行業Household & Personal Products
全職員工1,164

高階主管

名稱頭銜支付行使價出生年份
Mr. Jianya YanCEO & Executive Chairman of the Board733.78k1966
Dr. Fan DaidiChief Scientific Officer1967
Ms. Juan YeSenior VP & Executive Director925.06k1972
Ms. Juan FangSenior VP & Executive Director927.22k1974
Ms. Huijuan ZhangCFO & Executive Director1986
Ms. Yajuan YanSenior Vice President1970
Mr. Zhiguang DuanSenior Vice President1982
Ms. Yubo YanChief Product Officer, Joint Company Secretary & Executive Director1996
Ms. Wing Yan Yuen FCIS, FCSJoint Company Secretary1970
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.

公司管治

截至 無 止,巨子生物 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。